Some U.S. industry figures believe that the bureaucratic backlog is a "strategic excuse". A source from the U.S. rare earths ...

XIA: China's consumption upgrade is not only expanding market volume, but also elevating industry standards. As a global ...

Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.

Citigroup said on Monday it had appointed Wenjie Zhang as its new country officer and banking head for China, after the exit ...